Q3 2022

Source filing unavailable

Q3 2022 · —

Revenue

$168.19K

no prior Q3 2021 on file

Net Income

-$1.45M

no prior Q3 2021 on file

EPS Diluted

-$0.61

no prior Q3 2021 on file

Operating Income-$215,116—

Operating Cash Flowderived-$307,059—

Margins · derived

Same quarter

no prior Q3 2021 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

60 Degrees Pharmaceuticals, Inc. · CIK 1946563 · Engraved from SEC EDGAR